Citation

Breggin PR. Int. J. Risk Saf. Med. 1998; 11(1): 5-40.

Copyright

(Copyright © 1998, Elsevier Publishing)

DOI

unavailable

PMID

unavailable

Abstract

Electroconvulsive treatment (ECT) is increasingly used in North America and there are attempts to promote its further use world-wide. However, most controlled studies of efficacy in depression indicate that the treatment is no better than placebo with no positive effect on the rate of suicide. ECT is closed-head electrical injury, typically producing a delirium with global mental dysfunction (an acute organic brain syndrome). Significant irreversible effects from ECT are demonstrated by many studies, including: (1) Inventories of autobiographic and current events memories before and after ECT; (2) Retrospective subjective observations on memory; (3) Autopsy studies of animals and some of humans. ECT causes severe and irreversible brain neuropathology, including cell death. It can wipe out vast amounts of retrograde memory while producing permanent cognitive dysfunction. Contemporary ECT is more dangerous since the current doses are larger than those employed in earlier clinical and research studies. Elderly women, an especially vulnerable group, are becoming the most common target of ECT. Because of the lopsided risk/benefit ratio, because it is fundamentally traumatic in nature, because so many of the patients are vulnerable and unable to protect themselves, and because advocates of ECT fail to provide informed consent to patients-ECT should be banned.

Language: en

Keywords

adolescent; adult; aged; brain dysfunction; child; computer assisted tomography; depression; electroconvulsive therapy; europe; food and drug administration; human; law; medical ethics; north america; nuclear magnetic resonance imaging; politics; retrograde amnesia; review; risk benefit analysis; suicide